Validity of Predictive Markers for Post ERCP Pancreatitis Patients: A Single Centre Study

Authors

  • Michael Tendean Universitas Sam Ratulangi
  • Toar D. B. Mambu Universitas Sam Ratulangi
  • Leonard A. Melatunan Universitas Sam Ratulangi

DOI:

https://doi.org/10.35790/msj.v6i2.51513

Abstract

Abstract: Endoscopic retrograde cholangiopancreatography (ERCP) is a proprietary procedure, endoscopic modality, and specialized procedure used to diagnose and treat disorders of the pancreatic and biliary systems. The incidence of reported post-ERCP complications varied among several studies including post ERCP pancreatitis (PEP), duodenal perforation, and cholangitis. In this study, the author would like to show certain intra procedural factors related to PEP incidence. This was a retrospective study of secondary data of patients undergoing ERCP procedures from 2017-2022 at Prof. Dr. R. D. Kandou Hospital, Manado. Length of procedure, cannulation on pancreatic duct, pancreatogram, double wire technique, and the use of certain common bile duct (CBD) stone retrieval techniques such as endoscopic papillary balloon dilatation (EPBD) were recorded and analyzed. The results showed that based on the analyzed data, the percentage of pancreas cannulation was 8%, pancreatogram 5%, double-wire technique 3%, and EPBD procedure 10%, Incidence rate of PEP in all ERCP procedures was 19%. Increased amylase/lipase enzymes were found in 13 of 24 patients (54%) who underwent cannulation; 8 of 16 patients (50%) who underwent pancreatogram; 4 of 9 patients (44%) who underwent double wire procedure; and 10 of 30 patients (33%) who underwent EPBD. This PEP could be caused by several risk factors during ERCP including cannulation, pancreatogram, double wire, and EPBD. Number of cannulation attempt could result in trauma to the ampulla. Pancreatogram could result in hydrostatic, chemical, and allergic injury. Any manipulation of the pancreas that caused trauma could trigger the incidence of PEP. Assessment of the occurrence of PEP was based on increases in lipase and amylase enzyme values by four times the normal value and tested 6 hours after procedure. We could reduce the incidence of PEP by providing prophylactic therapy before ERCP. In conclusion, PEP is the most common complication in ERCP procedures and can be risky in patients with high risk factors. In this study, factors that affecting the incidence of PEP are cannulation, pancreatogram, double wire and EPBD.

Keywords: endoscopic retrograde cholangiopancreatography; pancreatitis; complications

Author Biographies

Michael Tendean, Universitas Sam Ratulangi

Division of Digestive Surgery, Department of Surgery, Faculty of Medicine, Universitas Sam Ratulangi, Manado, Indonesia

Toar D. B. Mambu, Universitas Sam Ratulangi

Division of Digestive Surgery, Department of Surgery, Faculty of Medicine, Universitas Sam Ratulangi, Manado, Indonesia

Leonard A. Melatunan, Universitas Sam Ratulangi

Department of Surgery, Faculty of Medicine, Universitas Sam Ratulangi, Manado, Indonesia

References

Katsinelos P, Lazaraki G, Chatzimavroudis G, Gkagkalis S, Vasiliadis I, Papeuthimiou A, et al. Risk factors for therapeutic ERCP-related complications. Ann Gastroenterol. 2014;27(1):65-72. Available from: https://pubmed.ncbi.nlm.nih.gov/24714755/

Morales SJ, Sampath K, Gardner TB. A review of preventive of Post-ERCP Pancreatitis, Gastroenterol Hepatol (N Y). 2018;14(5):286-92. Available from: https://pubmed.ncbi.nlm.nih.gov/29991936

Panda C, Das Haribhakti SD, Behera SK, Nath P. Restropective analysis of endoscopic retrograde cholangipancreatography (ERCP) procedurs in a tertiary care centre in coastal Odisha. International Journal of Research in Medical Sciences (IJRMS). 2017;5(10):4281-4. Doi: 10.18203/2320-6012.ijrms20174113

Parekh PJ, Majithia R, Sikka SK, Baron TH. The “scope” of Post ERCP Pancreatitis. Mayo Clin Proc. 2017;92(3):434-48. doi: 10.1016/j.mayocp.2016.10.028.

Crockett SD, Wani S, Gardner TB, Falck-Ytter, Barkun AN. Management of acute pancreatitis. Ann Gastroenterol. 2018;154(4):1096–101. Doi: 10.1053/j.gastro.2018.01.032

Singh V, Conwell LD, Banks AP. Acute pancreatitis In: GreenBerger J, Blumberg S, Burakoff R (editors). Current Diagnosis & Treatment: Gastroenterohepatology, Hepatology, and Endoscopy. McGraw-Hill Co. Inc. 2009; p. 291-8.

Iorgulescu A, Sandu I, Turcu F, Iordache N. Post-ERCP acute pancreatitis and its risk factors. J Med Life. 2013;6(1):109-13. Available from: https://pubmed,ncbi.nih.gov/23599832

WHO. Age Standarization of Rates. 2001. Available from: Age Standardization of Rates: A new WHO Standard

Vandevoort J, Soetikno RM, Tham TCK, Wong RCK, Ferrari Jr AP, Montes H, et al. Risk factors for complications after performance of ERCP. Gastrointest Endosc. 2002;56(5):652-6. Doi: 10.1067/mge.2002.129086

Thornton J, Axon A. Towards safer endoscopic retrograde cholangiopancreatography. Gut. 1993; 34(6):721-4. Doi: 10.1136/gut.34.6.721

Kobayashi G, Fujita N, Imaizumi K, Irisawa A, Suzuki M, Murakami A, e al. Wire-guided biliary cannulation technique does not reduce the risk of post-ERCP pancreatitis: multicenter randomized controlled trial. Dig Endosc. 2013;25(3):295-302. Doi: 10.1111/j.1443-1661.2012.01372.x

Lella F, Bagnolo F, Colombo E, Bonassi U. A simple way of avoiding post-ERCP pancreatitis. Gastrointest Endosc. 2004;59(7):830-4. Doi: 10.1016/s0016-5107(04)00363-3

Artifon ELA, Sakai P, Cunha JEM, Halwan B, Ishioka S, Kumar A. Guidewire cannulation reduces risk of post-ERCP pancreatitis and facilitates bile duct cannulation. Am J Gastroenterol. 2007; 102(10):2147-53. Doi: 10.1111/j.1572-0241.2007.01378.x

Pekgöz M. Post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review for prevention and treatment. World J Gastroenterol. 2019;25(29):4019-42. Doi: 10.3748/ wjg.v25.i29.4019

Downloads

Published

2024-01-28

How to Cite

Tendean, M., Mambu, T. D. B., & Melatunan, L. A. (2024). Validity of Predictive Markers for Post ERCP Pancreatitis Patients: A Single Centre Study. Medical Scope Journal, 6(2), 159–163. https://doi.org/10.35790/msj.v6i2.51513